2021-02-25T08:31:45Z
2021-02-25T08:31:45Z
2018-04-02
2021-02-25T08:31:45Z
Epigenetics is emerging as the missing link among genetic inheritance, environmental influences, and body and brain health status. In the brain, specific changes in nucleic acids or their associated proteins in neurons and glial cells might imprint differential patterns of gene activation that will favor either cognitive enhancement or cognitive loss for more than one generation. Furthermore, derangement of age-related epigenetic signaling is appearing as a significant risk factor for illnesses of aging, including neurodegeneration and Alzheimer's disease (AD). In addition, better knowledge of epigenetic mechanisms might provide hints and clues in the triggering and progression of AD. Intense research in experimental models suggests that molecular interventions for modulating epigenetic mechanisms might have therapeutic applications to promote cognitive maintenance through an advanced age. The SAMP8 mouse is a senescence model with AD traits in which the study of epigenetic alterations may unveil epigenetic therapies against the AD. Keywords: Aging, DNA methylation, epigenetics, histone modification, neurodegeneration
Article
Published version
English
Malaltia d'Alzheimer; Malalties neurodegeneratives; Envelliment; Epigenètica; Alzheimer's disease; Neurodegenerative Diseases; Aging; Epigenetics
IOS Press
Reproducció del document publicat a: https://doi.org/10.3233/JAD-170664
Journal of Alzheimer's Disease, 2018, vol. 62, num. 3, p. 943-963
https://doi.org/10.3233/JAD-170664
(c) Griñán Ferré, Christian et al., 2018